JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Identification of Jamp Emtricitabine/Tenofovir Disoproxil Fumarate
No description |
Google image searchProduct monograph
Active ingredients
tenofovir disoproxil fumarate, 300 MG
emtricitabine, 200 MG
DIN: 02487012
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 23-JUL-2019
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR03 — TENOFOVIR DISOPROXIL AND EMTRICITABINE (ATC/DDD)
Reference brand drug: Truvada
Pharmaceutical standard: MFR